M&A Deal Summary

Virbac Acquires Sasaeah

On April 1, 2024, Virbac acquired life science company Sasaeah

Acquisition Highlights
  • This is Virbac’s 4th transaction in the Life Science sector.
  • This is Virbac’s 1st transaction in Japan.

M&A Deal Summary
Date 2024-04-01
Target Sasaeah
Sector Life Science
Buyer(s) Virbac
Deal Type Add-on Acquisition

Target

Sasaeah

Tokyo, Japan
website
Sasaeah develops, manufactures, and markets a large portfolio of veterinary products targeting both farm animals and companion animals. Sasaeah is based in Tokyo, Japan.

Search 192,907 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Virbac

Carros, France

website

Category Company
Founded 1968
Sector Healthcare Services
Employees4,907
Revenue 1.2B EUR (2022)
DESCRIPTION

Virbac is an veterinarian independent pharmaceutical company. Virbac was founded in 1968 and is based in Carros, France.

DEAL STATS #
Overall 5 of 5
Sector (Life Science) 4 of 4
Type (Add-on Acquisition) 3 of 3
Country (Japan) 1 of 1
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-11-02 Globion

Hyderabad, India

Globion is a poultry vaccine specialist who has developed robust know-how and expertise in the development, manufacturing, and commercialization of live and inactivated vaccines targeting a large array of avian pathogens. Globion is based in Hyderabad, India.

Buy -
Mergr

Product

Company

Legal